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Abstract
Background: Arrhythmogenic right ventricular dysplasia (ARVD), is a genetic disorder of the heart, which mainly
involves the right ventricle. It is characterized by hypokinetic areas at the free wall of the right ventricle (RV) or both
ventricles, where myocardium is replaced by fibrous or fatty tissue. ARVD is an important cause of ventricular
arrhythmias in children and young adults. Although the transmission of the disease is based on hereditary, in
young adults it may not show any symptoms. The main differential diagnoses with other frequent etiological
causes of sudden arrhythmia are: idiopathic outflow tract ventricular tachycardia of the RV, myocarditis, dilated
cardiomyopathy and sarcoidosis.
Case presentation: We describe an unusual case of a 44-year-old woman who was hospitalized for ventricular
tachycardia, deep asthenia and dyspnoea with no previous history of cardiac disease. The patient had a ten-year
history of palpitations, which started immediately after her last pregnancy. She was diagnosed with both acute/
subacute viral myocarditis and arrhythmogenic right ventricular dysplasia, based on established clinical and cardiac
MRI criteria. After the diagnosis the patient received an automatic implantable cardioverter defibrillator. Currently,
she is on clinical follow-up with no apparent further complications.
Conclusion: Analyzing this rare case, we have shown the link between myocarditis and arrhythmogenic right
ventricular dysplasia, and how important is to perform a cardiac MRI, in the context of acute myocarditis and
ventricular arrhythmia.
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Background
Arrhythmogenic right ventricular dysplasia (ARVD), is a
genetic disorder of the heart, that mainly involves the right
ventricle [1, 2]. It is characterized by hypokinetic areas at
the free wall of the right ventricle (RV) or both ventricles,
where myocardium is replaced by fibrous or fatty tissue.
ARVD is an important cause of ventricular arrhythmias in
children and young adults. Although the transmission of
the disease is based on hereditary, in young adults it may
not show any symptoms. The main differential diagnoses
with other frequent etiological causes of sudden
arrhythmia are: idiopathic outflow tract ventricular tachy-
cardia of the RV, myocarditis [3], dilated cardiomyopathy
and sarcoidosis. We hereby describe a rare case of a
patient with both acute viral myocarditis and ARVD, as
assessed by echocardiography and cardiac MR (CMR).
Case presentation
The patient is a 44 year-old woman with a ten-year history
of palpitations, who started immediately after her last preg-
nancy. She wasn’t an active smoker and had a family history
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of cardiac disease (her father died at the age of 49 years-old
for myocardial infarction). The patient was admitted to the
emergency department for palpitations, deep asthenia and
dyspnoea appearing suddenly when she was at home, under
resting conditions. The patient was not febrile and did not
show any episodes of chest pain or syncope. At physical
examination, the patient revealed no symptoms of right
heart failure. ECG performed at her admission showed a
ventricular tachycardia (VT) with heart rate of 192 bpm
(Fig. 1). Initially the VT was treated by intravenous bolus of
lidocaine. For the resistance of the VT to lidocaine, was
injected an intravenous bolus of amiodarone and adeno-
sine. In response to the combined antiarrhythmic treat-
ment, the patient had a drop of systemic blood pressure
(80/50 mmHg), developed bradycardia (junctional rhythm
at 38 bpm) associated with dizziness. For this reason she
was moved to the coronary care unit (CCU). Here she was
treated with temporary endocardial pacing and hydration
therapy. Within 24 h the patient restored the sinus rhythm
and normal blood pressure. ECG recorded in sinus rhythm,
showed frequent polymorphic ectopic ventricular beats as-
sociated with negative T waves in right precordial leads. On
admission in CCU the blood tests revealed an elevated
troponin level (23 ng/mL, normal value: <5 ng/mL ng/mL)
and an elevated CK-MB level (1240 IU/L, normal value <
120 IU/L). The inflammation markers were also elevated
with a C-reactive protein (CRP) of 30,5 mg/L (normal
value: < 8 mg/L) and 21.000/mL white blood cells (normal
value: 4000-10000/mL). Her plasma electrolyte levels were
normal.
Echocardiography showed a normal geometry of the
left ventricle, with a slightly reduced systolic function
(EF: 51%), a normal diastolic pattern and mild tricuspid
regurgitation; the right ventricle was dilated with evi-
dence of hypokinesia of the apical segment and severely
reduced systolic function (TAPSE: 16 mm), hinting the
diagnosis of ARVD. CMR was performed using a super-
conducting system 1.5 T MR (Gyroscan Intera, Philips
Medical System, Best, The Netherlands) with a max-
imum gradient capability of 30 MT/m and maximum
slow rate of 150 MT/Ms. MR acquisition was triggered
by ECG and included a T1-weighted (T1W) sequence
and cine-MR images in the short-axis, and vertical long-
axis and horizontal long-axis planes for displaying
cardiac contraction. Short time inversion recovery
(STIR) T2-weighted (T2W) sequence was obtained to
suppress fatty tissue signal. Finally, three-dimensional
(3D) T1-delayed enhancement sequences, were acquired
at 10, 15 and 20 min, after the intravenous injection of
Gd-DTPA at a dose of 0.1 mmol/kg. CMR revealed find-
ings that were consistent with the major criteria of
arrhythmogenic right ventricular dysplasia: dilated right
ventricle with high end-diastolic volume (EDV) normal-
ized for body surface area (BSA) (116 mL/m2); right
ventricular dysfunction with ejection fraction (RVEF) of
18% and regional wall motion abnormalities (diffuse
hypokinesia, free wall iper-trabeculation, dyskinesia and
mid-RV free wall pseudo-aneurysm) (Fig. 2a and b). On
CMR there was a slightly reduced global left ventricular
systolic function (EF: 50%) with normal morpho-
Fig. 1 ECG performed on patient admission, showing a ventricular tachycardia with heart rate of 192 bpm
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volumetry of the left ventricle. CMR also revealed the
following findings that were consistent with a diagnosis
of acute/subacute viral myocarditis: diffuse edema of the
right ventricular free wall on STIR images (Fig. 3a and b),
associated with sub-epicardial late gadolinium enhance-
ment (Fig. 4a and b) of the same region. Overall, the
patient met the criteria for both ARVD and acute/sub
acute viral myocarditis. After the diagnosis the patient
received an automatic implantable cardioverter defibrilla-
tor (AICD) and a beta-blocker (Sotalol) was prescribed at
discharge. There was no recurrent VT up to the 4-month
follow-up. At 6-month follow-up, the patient complained
for palpitation and dizziness. AICD recordings demon-
strated 5 sustained VT episodes with appropriate device
intervention in all the cases. Transthoracic echocardiog-
raphy demonstrated a preserved systolic function of the
left ventricle (EF: 59%) and a dilated and hypokinetic
RV, owing a severely reduced systolic function (TAPSE =
14 mm, fractional change area of 30%). Currently, the
patient is on clinical follow-up with no apparent further
complications.
Discussion
ARVD is predominantly a genetically determined heart
muscle disorder, pathologically characterized by fibro-
fatty replacement of the right ventricular myocardium
[1, 2]. This pathology predisposes to ventricular arrhyth-
mias and sudden cardiac death and it can be divided in
three progressive phases: in the early “concealed phase”
patients are often asymptomatic; in the overt “electrical
phase” patients present with symptomatic arrhythmias;
finally, in the diffuse disease patients may present with
right, left or biventricular heart failure with associated
Fig. 2 Horizontal long axis (a) and short axis (b) balanced FFE images
showing a dilated right ventricle, with diffuse free wall iper-trabeculation
and dyskinesia, and mid-RV free wall pseudo-aneurysm. Bilateral pleural
effusion is also present; more conspicuous on the right side
Fig. 3 Horizontal long axis (a) and short axis (b) STIR-T2W images
showing a diffuse edema of the right ventricular free wall
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ventricular arrhythmias. Current Task Force Criteria for
ARVD diagnosis include, repolarization or depolarization
abnormalities on electrocardiography (ECG), presence of
ventricular arrhythmias, morphological and functional
changes, in addition to histopathology, family history, and
genetic findings [2]. Our patient fulfilled the major criteria
set by the Task Force [2, 3]: repolarization abnormalities
(inverted T waves in right precordial leads in the absence
of complete right bundle-branch block), sustained ven-
tricular tachycardia of left bundle-branch morphology
with superior axis, RV EDV to BSA ≥ 100 mL/m2 and
RVEF ≤ 40%, as assessed by echocardiography and CMR.
In addition, the patient fulfilled two of the Lake-Louise
criteria for CMR in acute myocarditis [4]. Infact, CMR
showed the presence of myocardial edema on STIR-
T2W sequences and sub-epicardial necrosis on post-
contrast T1W sequences; therefore, these imaging find-
ings added to troponin I and CK-MB release and an
elevation of CRP and white blood cells, strongly sug-
gested an acute myocarditis. Several studies have dem-
onstrated that myocarditis may affect the RV, causing
structural abnormalities, including microaneurysms, as
well as the arrhythmic manifestations that are typical of
ARVD. Some cardiotropic viruses (enterovirus or
adenovirus), detected in patients with sporadic ARVD,
were considered to have a potential role for the disease;
in fact the activation of inflammatory mediators, deter-
mined by the myocardial infection, could damage the
cardiac adherents junctions and the T-tubule system,
resulting in ventricular irritability and/or ion channel
disruption and consequent ARVD symptomatology [5].
However, this hypothesis is controversial, because the
inflammation could be a secondary event; infact, an
already diseased myocardium could have an increased
susceptibility to viral infection with resulting myocar-
dial inflammation [6]. Therefore, the precise relation-
ship between ARVD and acute myocarditis is not yet
determined [7].
In a previous manuscript, Mavrogeni et al. described
the case of a patient with Naxos disease, a recessively
inherited arrhythmogenic cardiomyopathy (ACM), char-
acterized by woolly hair and palmo-plantar keratoderma
[8]. This patient was asymptomatic and presented with
chest pain and increased troponin I. A deletion in plako-
globin (cell adhesion protein) gene (Pk2157del2TG) was
identified as the cause of Naxos disease [9]; therefore, it
has been proposed that a defect in proteins involved in
cell–cell adhesion, particularly under mechanical stress
conditions, could result in cell death and progressive
myocardial fibro-fatty replacement [10]. Moreover,
myocardial inflammatory infiltrates, frequently detected
in patients with ARVD, have been assumed as a reaction
to cell death rather than a consequence of an infective
process [11]. As described in recent papers, the reactive
nature of myocarditis in ARVD has been supported by
the massive inflammatory cell infiltrates found after
acute myocardial necrosis in early stages of disease in
desmoglein-2 transgenic animal model [12]. In particu-
lar, Kant et al. have shown the etiologic role of a deletion
of the adhesive extracellular domain of the desmosomal
cadherin in mice with an arrhythmogenic right ventricu-
lar cardiomyopathy like phenotype, with ventricular dila-
tion and fibrosis. Disturbed sarcomer structure, multiple
autophagic vacuoles and swollen mitochondria are typ-
ical findings of this cardiomyopathy, inducing cardio-
myocyte death, aseptic inflammation and fibrotic
replacement, with consequent impairment of the cardiac
function [13].
It must be underlined that in our case the patient started
to suffer of palpitations and fatigue for light efforts after giv-
ing birth her third child in 2009. Therefore, it is reasonable
to raise the hypothesis that pregnancy, the hormonal
changes and/or inflammatory stress occurring during preg-
nancy may unmask ARVD. Due to the rarity of cases, the
relation between the two events is not yet established.
Furthermore, idiopathic right ventricular outflow tract
Fig. 4 Early (a) and delayed (b) dynamic contrast enhanced 3D short axis images, showing abnormal contrast enhancement of the dilated right
ventricular free wall
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ventricular tachycardia, right ventricular myocardial in-
farction, dilated cardiomyopathy, myocarditis, pulmon-
ary hypertension, atrial and ventricular septal defects
are possible differential diagnoses including a dilated
right ventricle. Moreover, sarcoidosis with cardiac in-
volvement can mimic ARVC, making the differential
diagnosis very challenging. Uhl’s disease, an unusual
cardiac disorder with almost complete absence of right
ventricular myocardium, should also be considered as
differential diagnosis [14]. ARVD and myocarditis have
often different prognosis and treatment; in fact, the
former is a complex and progressive entity that requires
major clinical intervention, as AICD implantation, or
heart transplantation, while the latter is often a self-
limited pathology responding to a conservative approach.
To the best of our knowledge, only one case has been
published in the English literature showing in a 23 years
old man this rare linkage between ARVD and acute
myocarditis, based on echocardiography and CMR find-
ings [15]. In agreement with this article, in our case and
according to the current international task force consen-
sus statement for ARVD [16] the patient underwent an
AICD implantation and is currently in clinical follow up,
with no further complications.
In the case presented, CMR allowed the correct identi-
fication of the two different clinical entities; in addition,
the enhancement pattern as shown on delayed CMR
images, may also serve as a map for the exact location of
ablation or an endomyocardial biopsy [17].
Conclusions
This case shows the rare association between acute
myocarditis and ARVD, highlighting the importance
of a complete RV assessment through a CMR study
in the context of ventricular arrhythmia. CMR is the
most accurate and reproducible technique for asses-
sing the morphology and segmental wall motion of
the RV; in addition, it can evaluate the presence of
myocardial inflammation with specific STIR-T2W se-
quences and myocardial fibrosis or necrosis with
post-contrast T1W sequences, leading the physician
to the correct final diagnosis and to the most appro-
priate management of patients presenting with ven-
tricular arrhythmias.
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